IAIM
SRPT icon

Industrial Alliance Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

Industrial Alliance Investment Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-406
Closed -$46K – 142
2023
Q2 		$46K Buy
+406
New +$52.4K 0.02% 129

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Industrial Alliance Investment Management's SRPT Position: Q3 2023 in Review

Industrial Alliance Investment Management sold out of Sarepta Therapeutics (SRPT) in Q3 2023, closing a stake of 406 shares — an estimated $46K sold.

Industrial Alliance Investment Management first reported a position in SRPT in Q2 2023 and held it in 1 quarter. The position peaked at $46K in Q2 2023. 395 funds tracked by Wall St. Rank hold SRPT as of Q3 2023.

  • Industrial Alliance Investment Management reported no remaining Sarepta Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Industrial Alliance Investment Management sold 406 Sarepta Therapeutics shares in Q3 2023, an estimated $46K.
  • Industrial Alliance Investment Management first reported a position in Sarepta Therapeutics in Q2 2023 and held it in 1 quarter.
  • Industrial Alliance Investment Management's Sarepta Therapeutics position peaked at $46K in Q2 2023.
  • 395 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2023.

Based on Industrial Alliance Investment Management's 13F filing for Q3 2023, filed 15 Nov 2023.